CEO Glenn Abood is CEO of rfxcel, a supply chain track-and-trace company within the life sciences industry, helping companies meet regulatory compliance requirements, protect the product and ascertain brand reputation. The company, enables people, businesses and industries to protect end consumers and their products. This unique integrated software delivers better business outcomes and lowers overall costs.
The pharmaceutical industry’s understanding of serialization is maturing as companies slowly begin to recognize the added business value supply chain traceability can provide. Historically, the industry’s focus on serialization has been driven by the need to satisfy evolving regulations. However, companies are realizing that the benefits of traceability extend beyond compliance.
